Göran Eriksson
1 – 20 of 22
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Effect of nocturnal Temperature-controlled Laminar Airflow on the reduction of severe exacerbations in patients with severe allergic asthma : a meta-analysis
(
- Contribution to journal › Article
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
(
- Contribution to journal › Article
- 2020
-
Mark
A new maximal bicycle test using a prediction algorithm developed from four large COPD studies
(
- Contribution to journal › Article
-
Mark
Reduced variability of endurance time in new protocols for exercise tests in COPD
(
- Contribution to journal › Article
- 2019
-
Mark
Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma
(
- Contribution to journal › Article
-
Mark
Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial
(
- Contribution to journal › Article
- 2017
-
Mark
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
(
- Contribution to journal › Article
-
Mark
The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
(
- Contribution to journal › Article
-
Mark
A novel endpoint for exacerbations in asthma to accelerate clinical development : A post-hoc analysis of randomised controlled trials
(
- Contribution to journal › Article
- 2016
-
Mark
Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
(
- Contribution to journal › Article
-
Mark
Bronchodilator response of advanced lung function parameters depending on COPD severity
(
- Contribution to journal › Article
- 2015
-
Mark
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease.
(
- Contribution to journal › Article
-
Mark
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
(
- Contribution to journal › Article
-
Mark
A score to predict short-term risk of COPD exacerbations (SCOPEX).
(
- Contribution to journal › Article
-
Mark
A new approach to assess COPD by identifying lung function break-points.
(
- Contribution to journal › Article
- 2013
-
Mark
Factor analysis in predominantly severe COPD: Identification of disease heterogeneity by easily measurable characteristics
(
- Contribution to journal › Article
- 2011
-
Mark
Effect of different asthma treatments on risk of cold-related exacerbations
(
- Contribution to journal › Article
-
Mark
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
(
- Contribution to journal › Article
- 2010
-
Mark
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD
(
- Contribution to journal › Article
-
Mark
Measuring asthma control: a comparison of three classification systems
(
- Contribution to journal › Article